Biotech Startups
9,911 companies tagged Biotech, with their investors and founders.
Adamo Foods develops meat alternatives using a proprietary fermentation technology, producing fungi-based (mycelium) steaks and fillets. The company sells its plant-based products to restaurants.
2 investors
ADAXION develops deimmunized biologic therapies using its ADAx platform, which incorporates proprietary CD22 ligands to eliminate therapeutic-specific B cells and reduce anti-drug antibody responses. The company focuses on enabling biotherapeutics that would otherwise face prohibitive immunogenicity.
2 investors
ADC Therapeutics is a biopharmaceutical company that develops antibody drug conjugates and other therapies focused on hematology and oncology. It operates in the biotech and pharmaceutical industry.
2 investors
Addex Therapeutics is a clinical-stage pharmaceutical company that develops orally available small molecule drugs known as allosteric modulators for neurological disorders.
2 investors
AdipoPharma is a French biotech company developing PATAS, a first-in-class stapled peptide insulin sensitizer that targets adipocytes to treat insulin resistance, type 2 diabetes, and associated comorbidities. Its adipocyte-focused approach aims to address the root cause of type 2 diabetes, with its lead drug entering clinical trials in 2025.
2 investors
Adiposs develops ImageBAT, a contrast agent for medical imaging of brown fat that can identify patients at increased cancer risk and with higher treatment failure risk. The product serves oncology and metabolic health markets.
2 investors
Advarra is a human research compliance and review organization that operates institutional review boards (IRBs) and provides accreditation services for clinical research programs in accordance with U.S. federal regulations and international guidelines.
2 investors
Advertent Biotherapeutics is a biotechnology company developing first-in-class biologics that modulate TGF-ฮฒ family growth factors to protect muscle quality and promote regeneration in neuromuscular disorders, with a particular focus on muscular dystrophies. Founded in 2019 as a spin-out from Michigan State University, it targets high-unmet-need conditions where muscle degeneration and wasting cause disability.
2 investors
Adverum is a clinical-stage gene therapy company developing Ixo-vec, an investigational single-administration intravitreal treatment for wet age-related macular degeneration and other ocular diseases, based on a proprietary adeno-associated virus (AAV) vector platform. Its therapies aim to transform retinal cells into biofactories that continually produce anti-VEGF protein, reducing the need for frequent eye injections.
2 investors
Advion Interchim Scientific provides laboratory instruments, consumables, reagents, and software for chemical analysis and purification tasks such as chromatography, mass spectrometry, and ICP-MS. The company serves life science researchers and laboratories globally with identification, quantification, and purification solutions.
2 investors
AELIX Therapeutics is a company developing a therapeutic HIV vaccine intended for use in HIV cure and eradication strategies. It operates in the biotech and vaccine development sector.
2 investors
Aeromics is a clinical-stage pharmaceutical company developing AER-271, an intravenous aquaporin-4 (AQP4) inhibitor designed to prevent cerebral edema (brain swelling) following severe, acute ischemic stroke. Its approach targets molecular water channels to improve outcomes in neurological indications such as stroke, spinal cord injury, CNS surgery, and brain cancer.
2 investors
2 investors
Afyren produces bio-based organic acids derived from fermentation of non-food biomass to replace petroleum-derived molecules in consumer products and industrial applications. The company serves industrial manufacturers seeking alternatives to petrochemical ingredients across sectors including food, chemicals, and materials.
2 investors
Again is an AI-native biomanufacturing platform that uses computational biology and proprietary biological data to design molecules for chemicals, materials, agriculture, and food production, replacing traditional petrochemical manufacturing methods.
2 investors
Agile Therapeutics develops and markets contraceptive and women's health products using its proprietary Skinfusionยฎ transdermal technology platform. The company focuses on providing healthcare options for women through innovative delivery mechanisms.
2 investors
Agios is a biopharmaceutical company developing therapies for rare diseases, with a primary focus on hemolytic anemias including pyruvate kinase deficiency, thalassemia, and sickle cell disease. The company's approach is grounded in cellular metabolism research and involves close collaboration with patients and clinical partners.
2 investors
Agragene develops Precision-Guided Sterile Insect Technology (pgSIT) marketed as KNOCKOUTโข, a biocontrol product for controlling crop insect pests such as Spotted Wing Drosophila while reducing reliance on traditional insecticides. It serves agricultural growers of berries and cherries in the US and Canada, working alongside integrated pest management programs.
2 investors
Agrivida develops enzyme technology for animal feed and nutrition, improving efficiency in poultry, swine, and other livestock production. The company applies biochemical research to create solutions that enhance sustainable food production.
2 investors
AgroSustain develops pre- and post-harvest solutions for agricultural growers aimed at increasing crop yield and quality while reducing chemical use and preserving biodiversity. The company serves clients across the agricultural value chain with a focus on sustainable agriculture.
2 investors
AI Proteins designs engineered miniproteins for drug discovery and development in the biopharmaceutical industry. The company uses artificial intelligence to create novel protein-based therapeutics with improved efficacy, safety, and manufacturability compared to naturally evolved proteins.
2 investors
Aikium combines deep learning with large-scale wet-lab experimentation to design and screen protein libraries, aiming to develop protein therapeutics for hard-to-treat targets such as GPCRs and ion channels. The company focuses on drug discovery for parts of the human proteome that conventional antibodies and small molecules cannot address.
2 investors
AION Labs is a venture studio founded by pharmaceutical companies (AstraZeneca, Pfizer, Merck, Teva) alongside AWS and venture capital partners to build and scale companies applying AI and emerging technologies to drug discovery and development. It provides founders with early pharma validation, R&D expertise, mentorship, and capital to accelerate the creation of solutions that address unmet needs in pharmaceutical innovation.
2 investors
Airfinity provides AI-powered predictive analytics, simulation, and forecasting for the life sciences industry, focused on medicine and vaccine demand forecasting across specific disease areas. It serves biopharma companies, governments, and global health organisations to support decision-making.
2 investors